Johns Hopkins hematologic oncologist, Richard Ambinder, M.D., is one of the world's leading experts on Kaposi's sarcoma and other AIDS-associated cancers. Ambinder is director of the Division of Hematologic Malignancies at Johns Hopkins and leads a team of world-reknowned experts in blood and bone marrow cancers.
About AIDS-Associated Cancers
Cancers that commonly arise in AIDS patients include lymphomas and Kaposi's sarcoma. Other cancers also occur, and many are characterized by the presence of a virus in the cancer cells. Scientists are studying the role of those viruses and a weakened immune system in the growth and development of such cancers. Our physicians have played a major role in defining AIDS-related cancers and in developing therapeutic approaches to treat them.
Please consult your physician if any of the following symptomes persists for longer than 2 weeks: painless swelling in the lymph nodes in the neck, underarm, or groin; fever; night sweats; tiredness; weight loss without dieting; or itchy skin.
A variety of options are available for patients with AIDS-related cancers, ranging from chemotherapy and radiotherapy to biological interventions (enhancing or altering natural body responses to fight cancer) to supportive care. The choices are discussed with the patient by physicians with special interest and experience in the treatment of AIDS-related cancers.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is a leader in national programs for the treatment of new and relapsed AIDS-related cancers. There are many opportunities for participation in research studies and for treatment outside the research setting.